Grand Pharmaceutical Group Limited (0512) Financial Statements

5 Followers

Grand Pharmaceutical Group Limited Financial Overview

Grand Pharmaceutical Group Limited's market cap is currently HK$15.51B. The company's EPS TTM is HK$0.32; its P/E ratio is 13.53; and it has a dividend yield of 3.90%. Grand Pharmaceutical Group Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	HK$ 12.28B	HK$ 11.64B	HK$ 10.53B	HK$ 9.56B	HK$ 8.60B
Gross Profit	HK$ 6.78B	HK$ 6.74B	HK$ 6.52B	HK$ 5.95B	HK$ 5.25B
Operating Income	HK$ 1.04B	HK$ 2.17B	HK$ 2.66B	HK$ 2.52B	HK$ 2.02B
EBITDA	HK$ 2.35B	HK$ 3.39B	HK$ 2.97B	HK$ 3.09B	HK$ 3.10B
Net Income	HK$ 1.24B	HK$ 2.47B	HK$ 1.88B	HK$ 2.08B	HK$ 2.40B
Balance Sheet
Cash & Short-Term Investments	HK$ 2.09B	HK$ 3.14B	HK$ 2.47B	HK$ 2.48B	HK$ 2.87B
Total Assets	HK$ 27.17B	HK$ 24.99B	HK$ 22.52B	HK$ 22.37B	HK$ 21.06B
Total Debt	HK$ 4.72B	HK$ 4.44B	HK$ 3.40B	HK$ 4.48B	HK$ 3.65B
Net Debt	HK$ 3.56B	HK$ 3.10B	HK$ 2.06B	HK$ 3.03B	HK$ 1.89B
Total Liabilities	HK$ 9.99B	HK$ 8.47B	HK$ 7.24B	HK$ 8.16B	HK$ 7.61B
Stockholders' Equity	HK$ 17.02B	HK$ 16.47B	HK$ 15.16B	HK$ 14.14B	HK$ 13.39B
Cash Flow
Free Cash Flow	HK$ 774.37M	HK$ 1.28B	HK$ 1.93B	HK$ 245.79M	HK$ 1.49B
Operating Cash Flow	HK$ 1.50B	HK$ 1.90B	HK$ 2.42B	HK$ 1.92B	HK$ 2.01B
Investing Cash Flow	HK$ -952.79M	HK$ -2.00B	HK$ -515.75M	HK$ -2.58B	HK$ -1.77B
Financing Cash Flow	HK$ -795.17M	HK$ 29.96M	HK$ -1.89B	HK$ 464.49M	HK$ -333.17M

Currency in HKD

Grand Pharmaceutical Group Limited Earnings and Revenue History

Income Statement >

Grand Pharmaceutical Group Limited Liabilities to Assets

Balance Sheet >

Grand Pharmaceutical Group Limited Cash Flow

Cash Flow >

Grand Pharmaceutical Group Limited Forecast EPS vs Actual EPS

Earnings >

Grand Pharmaceutical Group Limited financials statements